Distinguish essential tremor from Parkinsons
- Trial ID
- NCT06378619
- Official Title
- Machine Learning Analysis Of The Tapping Test And The Archimedean Spiral For The Differential Diagnosis Of Essential Tremor And Parkinson's Disease.
- Goal
- Distinguish essential tremor from Parkinsons
- Status
- RECRUITING
- Sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf
- Study Type
- OBSERVATIONAL
- Enrollment
- 110 participants
- Conditions
- Tremor, Essential Tremor, Parkinson Disease
- Interventions
- Tapping Test, Archimedes Spiral
Plain-Language Summary
The goal is to help neurologists tell Parkinson's tremor from essential tremor more reliably using simple hand tests and computer analysis. People will do a finger tapping test and draw an Archimedean spiral while researchers measure speed, rhythm, tremor amplitude and tracing stability, then machine learning looks for patterns like slowed, irregular tapping with position-dependent tremor in Parkinson's versus the more regular kinetic tremor of essential tremor. The trial is enrolling people aged 45 to 79 who either have early-stage Parkinson's tremor with bradykinesia and Hoehn and Yahr stage 1 to 2, or have essential tremor diagnosed for at least 3 years with no bradykinesia. Individuals on antipsychotics, antidepressants, dopaminergic agonists or primidone, those with dyskinesias, severe tremor that prevents tracing, significant neuropathy, cognitive or affective problems, alcoholism, dystonia, prior stroke, or conflicting trial participation are excluded.
Locations
- Hospital Sant Camil-Consorci Sanitari Alt'Pènedes i Garraf, Barcelona, Catalonia, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Tapping Test. The goal is to help neurologists tell Parkinson's tremor from essential tremor more reliably using simple hand tests and computer analysis. People will do a finger tapping test and draw an Archimedean spiral while researchers measure speed, rhythm, tremor amplitude and tracing stability, then machine learning looks for patterns like slowed, irregular tapping with position-dependent tremor in Parkinson's versus the more regular kinetic tremor of essential tremor. The trial is enrolling people aged 45 to 79 who either have early-stage Parkinson's tremor with bradykinesia and Hoehn and Yahr stage 1 to 2, or have essential tremor diagnosed for at least 3 years with no bradykinesia. Individuals on antipsychotics, antidepressants, dopaminergic agonists or primidone, those with dyskinesias, severe tremor that prevents tracing, significant neuropathy, cognitive or affective problems, alcoholism, dystonia, prior stroke, or conflicting trial participation are excluded.
- Who can participate?
- Participants must be between 45 Years and 79 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.